Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled MR-monitored phase II trial

Bob W. van Oosten, Chris H. Polman, Alan McDougall et al.|Neurology|1997

Cited by 268